Real-world effectiveness and safety of lanadelumab for prophylaxis of hereditary angioedema attacks: 2-year interim results from the enable study

被引：0
|
作者：
Saguer, I. Martinez [1 ]
Cancian, M. [2 ]
Kinaciyan, T. [3 ]
Kessel, A. [4 ]
Andriotti, T. [5 ]
Botha, J. [6 ]
Wuillemin, W. [7 ,8 ]
机构：
[1] HRZM Hemophilia Ctr Rhein Main, Morfelden Walldorf, Germany
[2] Univ Hosp Padua, Padua, Italy
[3] Med Univ Vienna, Vienna, Austria
[4] Technion Fac Med, Bnai Zion Med Ctr, Haifa, Israel
[5] Takeda Dev Ctr Amer Inc, Lexington, KY USA
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
[7] Luzerner Kantonsspital, Luzern, Switzerland
[8] Univ Bern, Bern, Switzerland
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000847
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [31] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Naomi Hayase
    Mariko Yamada
    Shuhei Kaneko
    Yoko Watanabe
    Clinical and Experimental Nephrology, 2021, 25 : 660 - 673
  • [32] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Hayase, Naomi
    Yamada, Mariko
    Kaneko, Shuhei
    Watanabe, Yoko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (06) : 660 - 673
  • [33] Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
    Maria Petracca
    Serena Ruggieri
    Elena Barbuti
    Antonio Ianniello
    Roberta Fantozzi
    Giorgia Teresa Maniscalco
    Vincenzo Andreone
    Doriana Landi
    Girolama Alessandra Marfia
    Maria Di Gregorio
    Rosa Iodice
    Leonardo Sinisi
    Elisabetta Maida
    Rosanna Missione
    Cinzia Coppola
    Simona Bonavita
    Giovanna Borriello
    Diego Centonze
    Giacomo Lus
    Carlo Pozzilli
    Elisabetta Signoriello
    Neurology and Therapy, 2022, 11 : 1193 - 1208
  • [34] Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
    Petracca, Maria
    Ruggieri, Serena
    Barbuti, Elena
    Ianniello, Antonio
    Fantozzi, Roberta
    Maniscalco, Giorgia Teresa
    Andreone, Vincenzo
    Landi, Doriana
    Marfia, Girolama Alessandra
    Di Gregorio, Maria
    Iodice, Rosa
    Sinisi, Leonardo
    Maida, Elisabetta
    Missione, Rosanna
    Coppola, Cinzia
    Bonavita, Simona
    Borriello, Giovanna
    Centonze, Diego
    Lus, Giacomo
    Pozzilli, Carlo
    Signoriello, Elisabetta
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1193 - 1208
  • [35] Lanadelumab prophylaxis reduces breakthrough hereditary angioedema attacks and the need for rescue medication: Exploratory findings from the phase 3 HELP study
    Cicardi, M.
    Maurer, M.
    Longhurst, H. J.
    Johnston, D. T.
    Li, H. H.
    Nurse, C.
    Lu, P.
    Busse, P. J.
    ALLERGY, 2019, 74 : 212 - 212
  • [36] Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Long-Term Prophylaxis Use: Interim Results From the HELP Open-Label Extension Study
    Paes, Kim
    Craig, Timothy
    Bernstein, Jonathan
    Longhurst, Hilary
    Aygoren-Pursun, Emel
    Nurse, Christina
    Zuraw, Bruce
    Jacobs, Joshua
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB102 - AB102
  • [37] Real-world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2-year experience
    Fujiwara, Chisako
    Uchiyama, Akihiko
    Inoue, Yuta
    Ishikawa, Mai
    Motegi, Sei-ichiro
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 88 - 93
  • [38] Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study
    Calabrese, Laura
    Cinotti, Elisa
    D'onghia, Martina
    Cartocci, Alessandra
    Rubegni, Pietro
    Maccari, Francois
    Boulard, Claire
    Reguiai, Ziad
    Becherel, Pierre Andre
    Jacobzone, Caroline
    Begon, Edouard
    Fite, Charlotte
    Walls, Beatrice
    Liegeon, Anne Laure
    Parier, Josiane
    Chaby, Guillaume
    Perrot, Jean-Luc
    ACTA DERMATO-VENEREOLOGICA, 2025, 105
  • [39] Long-term safety and effectiveness of berotralstat (BCX7353) for the prophylaxis of hereditary angioedema (HAE) attacks: Results from the APeX-S study
    Kiani, Sorena
    Wu, Adrian
    Peter, Jonathan
    Reshef, Avner
    Maurer, Marcus
    Stobiecki, Marcin
    Kinaciyan, Tamar
    Aygoeren-Puersuen, Emel
    Best, Jessica
    Cornpropst, Melanie
    Sheridan, William P.
    Farkas, Henriette
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (01): : 172 - 173
  • [40] Real-world effectiveness of lanadelumab in European patients with HAE type I/II: Results from the retrospective integrated study
    Magerl, M.
    Bouillet, L.
    Saguer, I. Martinez
    Gavini, F.
    Andresen, I.
    Bent-Ennakhil, N.
    Sayegh, L.
    ALLERGY, 2023, 78 : 146 - 146
12345